Comments
Loading...

Cytokinetics

CYTKNASDAQ
Logo brought to you by Benzinga Data
$48.87
2.134.56%
At close: -
$48.87
-0.000500.00%
After Hours: Dec 20, 4:00 PM EDT
Cytokinetics (CYTK) sold assets to Sanofi (SNY) on Friday, December 20, 2024

Cytokinetics (NASDAQ:CYTK) Stock Quotes, Forecast and News Summary

Cytokinetics Stock (NASDAQ: CYTK) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
7
Sep
4
Oct
7
Nov
5
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$46.85
Close$48.87
Volume / Avg.3.81M / 1.20M
Day Range$46.85 - $50.32
52 Wk Range32.70 - 110.25
Market Cap$5.77B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
45
Short Interest
18.14%
Days to Cover10.39

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CYTK
LEGN

FAQ

Q

How do I buy Cytokinetics (CYTK) stock?

A

You can purchase shares of Cytokinetics (NASDAQ:CYTK) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Cytokinetics (CYTK) stock?

A

Cytokinetics has a consensus price target of $80.17.

Q

What is the current price for Cytokinetics (CYTK)?

A

The stock price for Cytokinetics (NASDAQ: CYTK) is $48.8695 last updated December 20, 2024 at 4:00 PM EST.

Q

Does Cytokinetics (CYTK) pay a dividend?

A

There are no upcoming dividends for Cytokinetics.

Q

When is Cytokinetics (NASDAQ:CYTK) reporting earnings?

A

Cytokinetics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.

Q

Is Cytokinetics (CYTK) going to split?

A

There is no upcoming split for Cytokinetics.

Q

What sector and industry does Cytokinetics (CYTK) operate in?

A

Cytokinetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch